The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.
about
Shining a light on intestinal trafficInflammatory pathways of importance for management of inflammatory bowel diseaseEctopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur?CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.CD4+CD25+ Regulatory T cell ontogeny and preferential migration to the cecal tonsils in chickensImmunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms.Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's Disease.Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn's-like murine ileitisUnexpected Regulatory Role of CCR9 in Regulatory T Cell Development.CCR9 Antagonists in the Treatment of Ulcerative Colitis.CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions.Leukocyte Trafficking to the Small Intestine and ColonIntestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.Activation and Recruitment of Regulatory T Cells via Chemokine Receptor Activation in Trichinella spiralis-Infected Mice.C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and DysfunctionThe effects of short-term high-fat feeding on exercise capacity: multi-tissue transcriptome changes by RNA sequencing analysis.Future treatment strategies for celiac disease.The role of regulatory T cells in neurodegenerative diseases.Targeting T-cell migration in inflammatory bowel disease.Vercirnon for the treatment of Crohn's disease.Advances in the treatment of coeliac disease: an immunopathogenic perspective.Current status of drugs in development for celiac disease.CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases.Allospecific Tregs Expanded After Anergization Remain Suppressive in Inflammatory Conditions but Lack Expression of Gut-homing Molecules.Protective effect of cigarette smoke on the course of dextran sulfate sodium-induced colitis is accompanied by lymphocyte subpopulation changes in the blood and colon.CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.Letter: the therapeutic potential of targeting CCL25/CCR9 in colonic inflammatory bowel disease - reading between the lines.Anti-inflammatory effects of epidermal growth factor on the immature human intestineChemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and PromiseEnhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment
P2860
Q26863227-624C1B40-CCA1-4552-A968-0545F9889D1CQ27005445-3ADC2EA9-EF85-43F3-938B-D9E1B400BA24Q28077990-1E525C89-4A53-47E3-B5A0-E3371942B848Q30371459-5E6D697A-275F-4318-98B7-6EDB54FBA8C2Q33769231-6E6EF860-5CEE-4F20-A79C-89154A7C0827Q34221840-8CA83C84-142C-4026-A436-F041242B0B55Q34737261-BB8850AB-CFC3-4F1A-ADE0-ECA83A5E9EC9Q34974051-C30451A9-570A-4C02-9056-44BB126240EFQ35627709-573CAB56-66A0-4804-A7D1-F7E1C39A30E8Q35730792-7C7F1A64-CAD2-4425-8AE0-766932231AA2Q36118943-01A401CC-E902-4694-B4FE-EBDBDFC479FCQ36291143-34FD5600-6F89-4DFE-8FE4-96A5BA1DCF67Q36592984-C1FA7D4A-57FC-42A2-9806-B7E20E658B72Q36715515-209115BD-E202-4BD3-B591-1463C762F259Q36911858-321DC93A-B303-4802-8115-9AE1C7F84280Q36956778-B600425D-BD8A-444C-9C2E-F706EC8A7D42Q37623005-2ED6BCF5-8C67-44B0-A340-F3C0CEC418CAQ38012460-FDD73916-407F-4EAB-AA55-F1CED53932F5Q38035240-6B3BE217-E6EE-420D-B496-3AEB59E16B5FQ38040430-A38EEA2F-943F-44BA-B110-E04A808AFC03Q38102750-84BA0409-B844-467E-A7D9-EA40DED82DCBQ38126789-EE791E54-75BD-48CF-BB49-BB025A7EE208Q38210088-2DF2633A-BDFF-4731-A44E-10E54FF6B205Q38432470-931751C9-4D67-4632-9AA8-B24A76BFD364Q38744708-9ED3D9F0-68F9-48E8-931F-B43EE1090C80Q42009496-C9A5BBF0-B384-4534-88B0-58AC027A7824Q42374248-973C779D-2BC5-4AC2-9535-0F16198FB64DQ45892815-C3796DB2-7866-48A4-A46D-A7883EE71AD3Q51665478-F6B7FF56-735C-49D7-B551-5A39EB1FCDD3Q57118129-3C936267-CD26-4E44-AAE1-BBE3FF0D03FEQ57168022-02EE11AE-DAAC-4F92-822B-305464E223FFQ57719084-6C6C2BDF-745F-477E-B11D-E311F45D3645
P2860
The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@ast
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@en
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@nl
type
label
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@ast
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@en
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@nl
prefLabel
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@ast
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@en
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@nl
P2093
P2860
P1433
P1476
The chemokine receptor CCR9 is ...... on of chronic ileitis in mice.
@en
P2093
Eoin N McNamee
Jesús Rivera-Nieves
Joshua D Wermers
Marc-André Wurbel
Paul Jedlicka
P2860
P304
1526-35.e3
P356
10.1053/J.GASTRO.2011.01.044
P407
P577
2011-02-04T00:00:00Z